John M. Taladay

John M. Taladay is Co-Chair of the Antitrust practice of Baker Botts. He is well-recognized as a leading global antitrust practitioner, known for his work in gaining merger approvals, defending criminal cartel investigations, litigating civil antitrust cases and managing complex international competition matters.

In working closely with the U.S. Federal Trade Commission, the U.S. Department of Justice Antitrust Division, the European Commission and other international agencies, Mr. Taladay has extensive experience in gaining merger clearances particularly in the technology, media, telecommunications, consumer products, software and pharmaceutical sectors and traditional industries including the automotive, airline, primary metals, agriculture, food, chemicals and electronics sectors.

Mr. Taladay has also led the defense of U.S. and foreign corporations and individuals in dozens of major cartel matters including antitrust grand jury investigations into allegations of price fixing, bid-rigging, market allocation and related offenses. He has navigated corporate clients through a range of cartel representation strategies from steadfast defense to leniency application to formal non-prosecution treatment. His litigation work includes acting as lead counsel in numerous civil antitrust class action and other litigation matters involving nearly all aspects of the antitrust laws.

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More

U.S. Universities: Engines of Economic Growth

By Sujai Shivakumar, Charles Wessner, Chris Borges, and Shruti Sharma Universities are among the United States’ most enduring sources of competitive advantage and a key pillar of the nation’s innovation system. Home to more than 35 of the world’s top 100 research universities, the United States owes many of its most
Read More

Andrei Iancu – Congressional Testimony: Hearing on the Patent Eligibility Restoration Act (PERA)

On October 8th, 2025, Andrei Iancu testified before the Senate Judiciary Committee, Subcommittee on Intellectual Property during the Hearing on the Patent Eligibility Restoration Act (PERA). Iancu, Partner at Sullivan & Cromwell, former Under Secretary of Commerce for IP and Director of the U.S. Patent and Trademark Office (USPTO), and
Read More